High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma
- PMID: 12325038
- DOI: 10.1002/mc.10076
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma
Abstract
Epigenetic changes in gene expression due to extensive CpG island methylation is now accepted as the main cause of inactivation of the p16 gene. More recently, it has been suggested that the human ras association domain family (RASSF) 1 gene, cloned from the lung tumor-suppressor locus 3p21.3, also may be inactivated by methylation. It consists of two major alternative transcripts, RASSF1A and RASSF1C. Epigenetic inactivation of isoform A was observed in several carcinomas and tumor cell lines. In this study, promoter hypermethylation of RASSF1A and p16 was investigated in 83 hepatocellular carcinoma (HCC) tissue samples from Taiwan and in two HCC cell lines (Hep3B and HepG2). High frequencies (85% and 47%, respectively) of methylation of the CpG island promoters of RASSF1A and p16 were found in the HCC tissues. The methylation of RASSF1A also was detected in Hep3B cells but not in HepG2 cells; p16 was not methylated in either cell line. Methylation status was determined in 12 normal control liver tissues and 10 adjacent nontumor tissues. No methylation was found in normal liver control tissues for both RASSF1A and p16; methylation was detected in one of 10 and seven of 10 adjacent nontumor tissue sampless for p16 and RASSF1A, respectively, in subjects with positive tumors. These data indicate that aberrant methylation of the CpG island promoters of both genes is a frequent occurrence in hepatocarcinogenesis. The high frequency of RASSF1A methylation in adjacent tissues suggests that this may be an early event. The relationship between methylation status and clinical parameters and tumor markers, including DNA damage resulting from aflatoxin B(1) (AFB(1)), an environmental carcinogen, and p53 status, also was analyzed. A statistically significant association was found between RASSF1A methylation status and the level of AFB(1)-DNA adducts in tumor tissues. No association was found between methylation status and p53 status. These results suggest the hypothesis that exposure to environmental carcinogens may be involved in altered methylation of genes involved in cancer development.
Copyright 2002 Wiley-Liss, Inc.
Similar articles
-
Frequent epigenetic silencing of the CpG island promoter of RASSF1A in thyroid carcinoma.Cancer Res. 2002 Jul 1;62(13):3698-701. Cancer Res. 2002. PMID: 12097277
-
Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma.Oncogene. 2003 Mar 27;22(12):1866-71. doi: 10.1038/sj.onc.1206338. Oncogene. 2003. PMID: 12660822
-
Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas.Clin Cancer Res. 2003 Aug 15;9(9):3376-82. Clin Cancer Res. 2003. PMID: 12960125
-
[Molecular genetic and epigenetic mechanisms of hepatocarcinogenesis].Ai Zheng. 2005 Jun;24(6):757-68. Ai Zheng. 2005. PMID: 15946497 Review. Chinese.
-
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future.Oncogene. 2002 Aug 12;21(35):5427-40. doi: 10.1038/sj.onc.1205600. Oncogene. 2002. PMID: 12154405 Review.
Cited by
-
Epigenetic basis of hepatocellular carcinoma: A network-based integrative meta-analysis.World J Hepatol. 2018 Jan 27;10(1):155-165. doi: 10.4254/wjh.v10.i1.155. World J Hepatol. 2018. PMID: 29399289 Free PMC article.
-
p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA).Medicine (Baltimore). 2017 Sep;96(38):e8106. doi: 10.1097/MD.0000000000008106. Medicine (Baltimore). 2017. PMID: 28930859 Free PMC article. Review.
-
P16 gene hypermethylation and hepatocellular carcinoma: a systematic review and meta-analysis.World J Gastroenterol. 2011 Jul 7;17(25):3043-8. doi: 10.3748/wjg.v17.i25.3043. World J Gastroenterol. 2011. PMID: 21799651 Free PMC article.
-
HCV and HCC Tango-Deciphering the Intricate Dance of Disease: A Review Article.Int J Mol Sci. 2023 Nov 7;24(22):16048. doi: 10.3390/ijms242216048. Int J Mol Sci. 2023. PMID: 38003240 Free PMC article. Review.
-
The innovative regularity and role of p16 methylation in blood during HCC development.J Cancer. 2018 Apr 27;9(11):1925-1931. doi: 10.7150/jca.23968. eCollection 2018. J Cancer. 2018. PMID: 29896276 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous